Statistics

Total Visits

Views
First-line bevacizumab and capecitabine-oxaliplatin in elderly patients with mCRC: GEMCAD phase II BECOX study85

Select a period of time:

Number of views in the range

Views
First-line bevacizumab and capecitabine-oxaliplatin in elderly patients with mCRC: GEMCAD phase II BECOX study35

Views

Views
December 20253
January 20261
February 20263
March 20263
April 20265
May 20264
June 202616
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States10
Netherlands10
United Kingdom2
Australia2
Argentina1
Canada1
Côte d'Ivoire1
Colombia1
Spain1
Finland1
 

Top cities views

Views
Groningen10
Aveiro1
Brooklyn1
Charlotte1
Derio1
Ennismore1
Helsinki1
Houston1
Lincoln1
Maiquetía1